Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (235 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
38.92
4,46,792
70.68
1,52,915
29.99
1,16,354
26.85
1,12,681
21.80
1,09,875
20.08
1,07,091
53.13
1,01,632
25.53
89,468
174
67,397
28.16
64,824
44.62
60,763
35.04
54,379
35.97
41,042
38.57
39,960
37.60
39,703
50.78
36,024
38.62
35,696
149
31,908
94.94
23,426
111
20,957
28.28
20,430
32.63
20,214
29.72
19,058
31.80
18,921
-
17,777
51.93
16,727
11.41
16,182
22.47
15,165
51.48
13,433
31.18
12,505
66.32
11,756
27.77
11,606
62.44
11,559
45.94
11,178
41.37
10,669
31.69
10,359
45.59
10,014
17.95
9,984
37.60
9,596
52.86
9,139
24.98
7,740
4.69
7,289
-
7,055
23.67
6,661
50.65
5,844
38.16
5,377
40.45
5,223
237
4,884
-
4,812
91.62
4,277
28.49
3,922
23.13
3,902
32.65
3,760
56.24
3,612
34.55
3,524
-
3,431
17.43
3,398
12.04
3,044
30.69
2,912
25.31
2,601
181
2,591
37.44
2,522
7.41
2,352
56.03
2,324
-
2,133
34.14
1,900
38.20
1,838
58.98
1,798
26.71
1,775
42.24
1,749
26.86
1,556
45.45
1,483
34.04
1,466
17.09
1,307
19.86
1,305
58.74
1,295
22.88
1,275
14.35
1,261
42.64
1,236
25.14
1,103
14.99
1,076
917
1,050
48.26
1,028
42.25
985
22.29
958
-
930
35.59
916
51.29
911
31.19
867
28.34
829
19.14
786
113
663
32.16
661
21.31
643
42.23
628
27.70
557
29.65
539
14.33
498
42.30
470
22.31
457
24.45
423
87.29
403
-
398
-
362
68.97
342
25.52
335
32.13
310
16.16
308
32.75
296
-
279
61.13
276
12.41
260
65.65
260
23.89
258
46.59
258
-
250
-
243
13.56
241
31.47
228
109
227
13.65
224
-
224
12.74
220
8.82
217
19.27
211
38.18
188
36.96
187
-
187
18.50
181
99.23
180
26.40
179
13.53
176
8.74
172
660
171
17.15
166
32.02
162
-
162
10.70
161
44.76
158
20.93
156
13.26
156
14.38
156
9.67
145
-
143
-
134
39.00
134
21.19
133
33.19
132
21.59
131
18.75
130
29.85
122
66.70
121
20.12
116
25.85
106
95.32
101
11.93
100
20.19
98
23.58
95
7.79
89
36.97
87
11.92
82
20.12
79
-
76
20.45
70
17.84
69
3.93
69
-
67
-
67
-
65
32.85
63
112
61
21.02
59
11.63
58
36.69
57
-
56
121
55
-
51
11.96
50
5.41
49
15.51
49
-
48
-
45
-
45
19.61
45
99.65
44
-
43
10.08
42
25.80
40
19.13
39
-
37
451
37
10.87
33
13.31
33
26.51
32
50.81
30
4.67
30
-
29
4.73
28
-
28
7.92
27
12.19
27
31.22
27
-
27
9.58
24
29.30
23
-
23
-
21
85.63
21
-
21
34.72
20
14.82
19
37.10
19
157
19
-
18
3,288
16
-
14
-
14
-
14
-
13
28.65
13
8.20
13
157
12
28.04
12
12.08
9
-
8
-
7
-
7
89.76
7
84.46
7
-
7
-
5
69.81
4
-
4
-
3
-
2
Showing 5 235 of 235 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material